PRESCRIBING CONTROLLED SUBSTANCES SAFELY: A DEA REQUIREMENT Final Examination Questions Select the best answer for each question and complete your test online at EliteLearning.com/Book
46. Which of the following U.S. federal agencies is NOT involved in scheduling controlled substances? a. Drug Enforcement Agency (DEA). b. Food and Drug Administration (FDA). c. Centers for Medicare and Medicaid (CMS). d. Department of Health and Human Services (HHS). 47. Which DEA Controlled Substance Schedule is associated with the lowest risk of abuse? a. Schedule II. b. Schedule III. c. Schedule IV. d. Schedule V. 48. When prescribing controlled substances, refills may be pre - scribed on all prescriptions EXCEPT for: a. Schedule I. b. Schedule II. c. Schedule III. d. Schedule IV. 49. According to federal law, a controlled substance prescription may be transmitted in one of the following ways: a. Faxed prescription.
51. Factors that associate inappropriate prescribing of opioid analgesics and illicit drug use include all of the following EXCEPT: a. Acute pain opioid analgesic prescription for three days or less. b. Initial acute pain opioid analgesic prescription for a 10-day supply. c. Cumulative dose of 700 MME. d. Refill of acute pain opioid prescription. 52. Which concepts are NOT associated with appropriate pre- scribing and monitoring acute opioid analgesic therapy? a. Use the lowest effective dose for initial treatment. b. Utilize other nonopioid treatment modalities to decrease the opioid burden. c. The duration of treatment for acute pain is usually great- er than 10 days. d. Secure storage of opioid prescriptions is important. 53. When individualizing opioid therapy regimens, which of the following would NOT lead to a heightened degree of caution? a. Patients receiving ACE inhibitors for the treatment of hy- pertension. b. Patients receiving benzodiazepine as a muscle relaxant. c. A woman who is breastfeeding. d. Patients with psychiatric disorders. 54. To treat pain, it is appropriate to use extended-release or long-acting opioids in opioid naïve patients. a. True. b. False. 55. Monitoring of patients with chronic pain should include which of the following? a. Objective assessment of functional improvements. b. Review of state PDMP. c. Evaluation for any opioid-related side effects. d. All of the above.
b. Telephone prescription. c. Electronic prescription. d. All of the above.
50. Morphine milligram equivalents (MME) were developed to assist clinicians with determining equal dosages when con- verting patients from one opioid analgesic to another.
a. True. b. False.
Course Code: RPTX08DR
Page 81
Book Code: RPUS3024
EliteLearning.com/Pharmacy
Powered by FlippingBook